Interferons: Cytokines in Autoimmunity
- 28 September 2007
- book chapter
- Published by Wiley
- Vol. 129, 223-233
- https://doi.org/10.1002/9780470513484.ch15
Abstract
The presence of circulating interferons in the blood of patients with autoimmune diseases and the acquired immune deficiency syndrome (AIDS) raises the question of their possible pathogenetic or defence functions. Interferons control levels of HLA class I and II antigens on cells and can activate or inhibit immune killer cell activities. Tumour necrosis factors (TNF) and interleukin 1 induce a new autocrine species of interferon known as IFN‐β‐2 whose gene has been cloned, sequenced and expressed. This IFN mediates the increase in HLA expression caused by TNF as well as the antiviral activity of this cytotoxin.Keywords
This publication has 42 references indexed in Scilit:
- Effects of interferon-α on the expression of a lupus idiotype in normal humansClinical Immunology and Immunopathology, 1986
- There is more than one interleukin 1Immunology Today, 1986
- WHAT PREVENTS AUTOIMMUNITY?The Lancet, 1985
- In Situ Characterization of Autoimmune Phenomena and Expression of HLA Molecules in the Pancreas in Diabetic InsulitisNew England Journal of Medicine, 1985
- Activated suppressor T cells and the role of interferon in aplastic anaemiaImmunology Today, 1985
- The physiological interferon responseImmunology Today, 1985
- The effect of gamma-interferon on MHC antigensImmunology Today, 1984
- The basis of autoimmunity in MRL-lpr/lpr mice: a role for self Ia-reactive T cellsImmunology Today, 1984
- Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.The Journal of Experimental Medicine, 1983
- Immune Interferon in the Circulation of Patients with Autoimmune DiseaseNew England Journal of Medicine, 1979